Form 6-K ASTRAZENECA PLC For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
AstraZeneca (AZN) Tops Q3 EPS by 90c, Beats on Revenue
November 10, 2022 5:36 AM ESTAstraZeneca (NASDAQ: AZN) reported Q3 EPS of $1.67, $0.90 better than the analyst estimate of $0.77. Revenue for the quarter came in at $10.98 billion versus the consensus estimate of $10.78 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
... More